Danaher Corp (NYSE:DHR)
$ 234.34 -1.57 (-0.67%) Market Cap: 170.39 Bil Enterprise Value: 181.11 Bil PE Ratio: 45.02 PB Ratio: 3.32 GF Score: 87/100

Danaher Corp at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 11, 2022 / 04:15PM GMT
Release Date Price: $270.64 (+0.76%)
Tycho W. Peterson
JPMorgan Chase & Co, Research Division - Senior Analyst

Good morning, everybody. I'm Tycho Peterson from the life science team. It's my pleasure to introduce our next company this morning, Danaher.

Just a quick reminder for people that have questions, you can submit questions through the ask a question function on the website. And with that, let me turn it over to Rainer.

Rainer M. Blair
Danaher Corporation - President, CEO & Director

Well, thank you, Tycho, and good morning, and thank you also to JPMorgan for hosting. I certainly hope we can all be together in person again here real soon. Now I know we have some slides for you to view. So let's go to the second slide here. Just briefly, that's our forward-looking statements, and those are there for your reference. But we can now jump right into really the third slide.

And let me start with an update on our preliminary results for the fourth quarter of 2021. As you likely saw, we made an announcement earlier this morning around our preliminary look at the fourth

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot